Results 211 to 220 of about 115,987 (377)

Food protein hydrolysates as a source of dipeptidyl peptidase IV inhibitory peptides for the management of type 2 diabetes [PDF]

, 2013
Orla Power, Alice B. Nongonierma, Philip M. Jakeman, Richard J. Fitzgerald   +3 more
openalex   +1 more source

Dipeptidyl Peptidase 4 [PDF]

, 2020
openaire   +1 more source

Sodium–glucose cotransporter 2 inhibitors for hypertension in cardiovascular–kidney–metabolic syndrome

Experimental Physiology, EarlyView.
Abstract The antihypertensive mechanism of sodium–glucose cotransporter 2 (SGLT2) inhibitors has been traditionally attributed to osmotic diuresis. However, emerging evidence reveals multifaceted mechanisms beyond diuresis, including regulation of the renin–angiotensin–aldosterone system, sympathetic nervous system suppression, ion homeostasis ...
Chunxiang Xu, Xingyu Qiu, Nan Xu, Gensheng Zhang, Enyin Lai, Liang Zhao   +5 more
wiley   +1 more source

Targeting high circulating dipeptidyl peptidase 3 in circulatory failure. [PDF]

Crit Care
Picod A, Azibani F, Harjola VP, Karakas M, Kimmoun A, Levy B, Pickkers P, Thiele H, Zeymer U, Santos K, Mebazaa A.   +10 more
europepmc   +1 more source

Evaluation of Risk of Bullous Pemphigoid With Initiation of Dipeptidyl Peptidase–4 Inhibitor vs Second-generation Sulfonylurea

, 2020
Hemin Lee, Hye Jin Chung, Ajinkya Pawar, Elisabetta Patorno, Dae Hyun Kim   +4 more
openalex   +2 more sources

Modulation of Kv4.2 Channel Expression and Gating by Dipeptidyl Peptidase 10 (DPP10) [PDF]

, 2004
Henry H. Jerng, Yan Qian, Paul J. Pfaffinger   +2 more
openalex   +1 more source

Targeting Tumor Dormancy and Recurrence: Molecular Mechanisms and Peptide Therapeutic Delivery

MedComm – Oncology, Volume 5, Issue 1, March 2026.
This review summarizes the molecular mechanisms that regulate tumor dormancy and its role in cancer recurrence, with emphasis on immune evasion, extracellular matrix remodeling, metabolic regulation and angiogenic switching. It further discusses emerging peptide–based therapeutic strategies aimed at detecting, modulating, and eliminating dormant tumor ...
Abdur Raheem Aleem, Atif Ali, Wajid Ali, Yuying Cheng, Zhibin Yan, Chaoyi Xia, Chenguang Liu, Caiyun Fu, Yiren Hu, Xi Wang   +9 more
wiley   +1 more source

ERRATUM: Effects of dipeptidyl peptidase-4 inhibitor in insulin-resistant rats with myocardial infarction. [PDF]

J Endocrinol
Apaijai N, Inthachai T, Lekawanvijit S, Chattipakorn SC, Chattipakorn N.   +4 more
europepmc   +1 more source

IMPACT OF TYPE 2 DIABETES-ASSOCIATED DIPEPTIDYL PEPTIDASE-4 (DPP-4) MUTATIONS ON LIGAND BINDING AND ENZYME ACTIVITY MODULATED BY NATURAL COMPOUNDS

Gizem KÖPRÜLÜLÜ KÜÇÜK
openalex   +2 more sources

Efficacy, safety and dose–response relationship of teneligliptin, a dipeptidyl peptidase‐4 inhibitor, in Japanese patients with type 2 diabetes mellitus [PDF]

, 2013
Takashi Kadowaki, Kazuoki Kondo
openalex   +1 more source